Filing Details

Accession Number:
0000899243-18-003580
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-02-12 18:21:55
Reporting Period:
2018-02-08
Accepted Time:
2018-02-12 18:21:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1596946 Quotient Ltd QTNT In Vitro & In Vivo Diagnostic Substances (2835) 264719797
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1605065 Brian Mcdonough 28 Esplanade
St Helier Y9 JE2 3QA
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2018-02-08 10,000 $3.87 47,747 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Ordinary Shares Ordinary Share Option (Right to Buy) $8.00 2024-04-29 10,000 10,000 Direct
Ordinary Shares Options to purchase ordinary shares $0.00 2022-11-14 2022-08-30 40,029 40,029 Direct
Ordinary Shares Ordinary Share Option (Right to Buy) $9.95 2024-10-31 5,025 5,025 Direct
Ordinary Shares Ordinary Share Option (Right to Buy) $11.62 2025-10-31 4,303 4,303 Direct
Ordinary Shares Ordinary Share Option (Right to Buy) $5.73 2026-10-31 8,726 8,726 Direct
Ordinary Shares Restricted Stock Units $0.00 2,618 2,618 Direct
Ordinary Shares Warrant $5.80 2018-07-31 10,493 10,493 Direct
Ordinary Shares Ordinary Share Option (Right to Buy) $5.21 2027-10-31 9,597 9,597 Direct
Ordinary Shares Restricted Stock Units $0.00 5,758 5,758 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2024-04-29 10,000 10,000 Direct
2022-08-30 40,029 40,029 Direct
2024-10-31 5,025 5,025 Direct
2025-10-31 4,303 4,303 Direct
2026-10-31 8,726 8,726 Direct
2,618 2,618 Direct
2018-07-31 10,493 10,493 Direct
2027-10-31 9,597 9,597 Direct
5,758 5,758 Direct
Footnotes
  1. All 10,000 options have vested and remain exercisable.
  2. The exercise price will be paid in pounds sterling, at GBP 0.91 per share.
  3. All 5,025 options have vested and remain exercisable.
  4. 2,868 options have vested and remain exercisable, 1,435 options will vest on October 31, 2018.
  5. 2,909 options vested on October 31, 2017 and remain exercisable, 2,909 options will vest on October 31, 2018, 2,908 options will vest on October 31, 2019.
  6. Restricted Stock Units covert into ordinary shares on a one-for-one basis.
  7. On October 31, 2016, the Reporting Person was granted 5,236 restricted stock units, of which 2,618 have vested and have been exercised. The remaining 2,618 restricted stock units will vest on October 31, 2018.
  8. The warrants are immediately exercisable.
  9. The options vest and become exercisable in three equal annual installments beginning October 31, 2018.
  10. On October 31, 2017, the Reporting Person was granted 5,758 restricted stock units, vesting in two equal installments on October 31, 2018 and October 31, 2019.